English
Arabic
Chinese (Simplified)
Dutch
Esperanto
French
German
Greek
Italian
Japanese
Korean
Portuguese
Russian
Spanish
UrduCoronavirus vaccines are rolling out across the country, so, what does that mean for the outlook of the pandemic?
Tag: Vaccine
Rutgers Experts Available to Discuss Moderna Coronavirus Vaccine Rollout
Rutgers medical experts are available to discuss the FDA’s approval of Moderna’s coronavirus vaccine for emergency use and its rollout. The Rutgers New Jersey Medical School is one of only two sites for the Phase 3 trial of the Moderna…
COVID-19 Vaccines: Nurses Continue to Lead
The American Association of Critical-Care Nurses has released a statement strongly recommending that nurses be vaccinated against COVID-19. In the statement, the organization addresses the nuanced sense of pride and anxiety felt by nurses and other healthcare professionals who have been given top priority to receive the first COVID-19 vaccines.
Researchers discover new way to deliver DNA-based therapies for diseases
University of Minnesota Twin Cities researchers have created a new polymer to deliver DNA and RNA-based therapies for diseases. For the first time in the industry, the researchers were able to see exactly how polymers interact with human cells when delivering medicines into the body. This discovery opens the door for more widespread use of polymers in applications like gene therapy and vaccine development.
COVID-19 vaccination begins at UChicago Medicine
First UChicago Medicine employees vaccinated against SARS-CoV-2; Paves way for thousands more to be scheduled over next several weeks
Some States May Lack Facilities for Administering Covid-19 Vaccine to Residents
As the biggest vaccination effort in U.S. history gets underway, several states may not have enough facilities in some areas to administer the COVID-19 vaccine to all residents who want it, according to a new analysis from the University of Pittsburgh School of Pharmacy and the nonprofit West Health.
George Washington University Public Health/Medical Experts Available for Media Interviews on COVID-19 Vaccine
On Dec. 17, a U.S. Food and Drug Administration panel is expected to review the data on the Moderna COVID-19 vaccine, paving the way for approval. Researchers at the George Washington University led one of the 100 clinical sites testing…
Memorial Hermann First in Houston to Administer COVID-19 Vaccine to Frontline Healthcare Workers
Key Takeaways:
• Memorial Hermann is proud to be part of history in the making, as the first health systems across the country begin receiving and administering the Pfizer COVID-19 vaccine to their frontline healthcare workers
• Memorial Hermann’s first vaccine was given to Robert Luckey, a nurse in the COVID ICU at Memorial Hermann-Texas Medical Center
• To date, Memorial Hermann has treated more than 12,000 COVID-19 positive patients in its hospitals, more than any other health system in the Greater Houston area
• The system expects to receive 16,575 doses of the Pfizer vaccine in the first allotment, more than any other health system in the Greater Houston area
• It’s important that everyone continues practicing the three “W’s”: wearing a mask, watching social distance and washing hands frequently
@rmalosh infectious disease epidemiologist @umsph and leukemia survivor discusses why he’s planning on getting the COVID-19 vaccine
FACULTY Q&A Video U-M expert, leukemia survivor discusses why he’s planning on getting the COVID-19 vaccine Ryan Malosh is an assistant research scientist at the University of Michigan School of Public Health whose research focuses on infectious disease and vaccine…
AACI Applauds Approval of COVID-19 Vaccine, Supports Widespread Vaccination Efforts
The Association of American Cancer Institutes (AACI) commends the U.S. Food and Drug Administration (FDA) for its swift action to grant Emergency Use Authorization (EUA) to Pfizer’s COVID-19 vaccine.
Early Access to COVID-19 Vaccination Essential for Anesthesia Professionals, ASA Says
With the first round of COVID-19 vaccines being deployed to states across the country, the American Society of Anesthesiologists (ASA) advises that anesthesia professionals, and other frontline health care workers, be prioritized to receive early access to the COVID-19 vaccination given their high risk of exposure to the virus in operating rooms, labor and delivery suites, procedural areas, emergency rooms and critical care units.
Story Tips from Johns Hopkins Experts on Covid-19
Vaccines that prevent infection by SARS-CoV-2, the virus that causes COVID-19, are being rolled out around the world. Below are five things about vaccine science of which you may be unaware. Additionally, here is a video about how vaccines are determined safe.
First doses of COVID-19 vaccine in Canada given by University Health Network
University Health Network (UHN) today gave the first COVID-19 vaccine in Canada. This landmark event signals a potential turning point in the pandemic and underlines the value of science and worldwide cooperation.
Vaccine experts weigh in on safety, history and possible resistance to the recently approved COVID-19 vaccine.
AMES, Iowa – The Food and Drug Administration granted emergency use authorization for the first of several COVID-19 vaccines seeking its approval. As distribution begins, Iowa State University experts are available to comment on the safety of the vaccine, the…
Pre-existing influenza immunity impacts antibody quality following seasonal infection and vaccination
New research by scientists at the University of Chicago suggests a person’s antibody response to influenza viruses is dramatically shaped by their pre-existing immunity, and that the quality of this response differs in individuals who are vaccinated or naturally infected. Their results highlight the importance of receiving the annual flu vaccine to induce the most protective immune response.
Rutgers Expert Available to Discuss Rich Countries Hoarding Coronavirus Vaccine
Richard Marlink, director of the Rutgers Global Health Institute, is available to discuss the global health impact of coronavirus vaccine hoarding by rich countries and how such measures may derail worldwide efforts in fighting the pandemic. “Hoarding of vaccines by…
Penn Medicine mRNA Vaccine Technology Pioneer and Health Policy Experts Join Together to Discuss COVID Vaccine Emergency Use Authorization Plans
**All experts also available for interviews prior to event and EUA Advisory Committee Meetings**
**B-roll and lab photos of Drs. Weissman and Wherry shot this month, headshots of the others, and photos from Penn’s Moderna vaccine trial participants getting vaccinated, are available for use**
Free Webinar—Next Steps in Eradicating COVID-19: Emerging Treatments and Vaccines
In this free STS webinar, Next Steps in Eradicating COVID-19: Emerging Treatments and Vaccines, STS President Dr. Joseph Dearani will talk with infectious disease experts from the White House Coronavirus Task Force and Mayo Clinic about promising new treatments and preventive measures.
BIDMC researchers define immune system’s requirements for protection against COVID-19
In a new paper in the journal Nature, BIDMC researchers shed light on the role of antibodies and immune cells in protection against SARS-CoV-2, the virus that causes COVID-19, in rhesus macaques.
UNLV Immunologist on the Differences Between Two Leading COVID-19 Vaccine Candidates
Millions around the world have waited for news about a COVID-19 vaccine, regarding it as the beginning of the end for the global pandemic and a herald for the eventual return to “normal life.” Recent announcements from pharmaceutical companies Pfizer and Moderna that their respective late-stage vaccine trials have shown a 90% or better effectiveness rate have received international applause, excitement furthered with estimates that doses could be ready as early as December.
Over half of adults over 50 say they’ll get vaccinated against COVID-19, but many will want to wait, poll finds
A new poll of adults ages 50 to 80 suggests that achieving the widespread vaccination against COVID-19 needed to protect this high-risk group and end the pandemic will be an uphill climb, and require clear, transparent communication from health providers and others.
UAlbany Experts Available to Discuss COVID-19 Vaccine Rollout
ALBANY, N.Y. (Nov. 19, 2020) – The United States has now surpassed 11 million COVID-19 cases since February and many Americans are scrambling to figure out how to safely celebrate the upcoming holiday season. But, promising vaccine news could signal…
Experts Issue Recommendations for Equitable Distribution of COVID-19 Vaccine
A group of vaccine experts led by Children’s Hospital of Philadelphia (CHOP) has published recommendations to ensure equitable distribution of a COVID-19 vaccine when it becomes available. The framework, published today in Heath Affairs, focuses on five principles the authors believe would strengthen the current immunization delivery system to ensure equitable access to everyone for whom vaccination is recommended.
Rutgers Infectious Disease Expert Available to Discuss Moderna’s Coronavirus Vaccine
Rutgers’ principal investigator for the Moderna phase 3 coronavirus vaccine clinical trial at Rutgers New Jersey Medical School is available to discuss the drugmaker’s vaccine, which the company has announced is 94.5 percent effective. Moderna intends to seek an emergency…
Pfizer, Moderna news is promising, but billions are unlike to get COVID-19 vaccine for years
In just a week, both Moderna and Pfizer have announced that they have developed effective vaccines against COVID-19 — but how long will it be before everyone has access to them? According to Nicole Hassoun, professor of philosophy at Binghamton…
Mount Sinai Researchers Discover How to Boost Efficacy of Vaccine Designed to Prevent Melanoma Recurrence
A vaccine created to prevent the recurrence of the deadly skin cancer melanoma is about twice as effective when patients also receive two components that boost the number and effectiveness of immune system cells called dendritic cells, according to phase 2 clinical trial results published in Nature Cancer in November.
What We Know: Mount Sinai to Host COVID-19 Research Symposium
The COVID-19 Research Symposium, hosted by the Mount Sinai Clinical Intelligence Center (MSCIC), is a one-day comprehensive review of advances in research by the Mount Sinai Health System to better understand and treat the coronavirus known as COVID-19.
MTU, UMass researchers preserve viral vaccines without refrigeration
Half of vaccines are wasted annually because they aren’t kept cold. Michigan Tech and UMass Amherst chemical engineers have discovered a way to stabilize viruses in vaccines with proteins instead of temperature.
Expert available to discuss best methods for communicating about COVID-19 vaccine
On Monday, Pfizer announced early results from its coronavirus vaccine trial that showed their vaccine is more than 90 percent effective – signaling that the vaccine may be closer than ever to being distributed. Katharine Head, an associate professor of…
.@umichsph researcher @rmalosh discusses the results of the interim efficacy analysis, shared today by Pfizer and BioNTech, is available to discuss with the media.
Ryan Malosh, assistant research scientist at the University of Michigan School of Public Health, can comment on today’s announcement by Pfizer and BioNTech. His research focuses on vaccine effectiveness, epidemiology and transmission of respiratory viruses, and social determinants of acute…
Fighting Zika? Call in the T cells
In a new Science Advances study, Shresta and her colleagues at LJI report that the immune system’s T cells have the power to prevent Zika infection in mice. This finding suggests that effective Zika vaccines need to activate T cells to work alongside antibodies.
Iowa awards $2 million CARES Act grant to universities to study COVID-19 nanovaccine
The state of Iowa has designated $2 million in federal CARES Act funding to support university research and development of a nanovaccine to protect against COVID-19 infections. Researchers at Iowa State University and the University of Iowa will work together on a needle-free, single-dose nanovaccine.
Surgeon General expects COVID-19 vaccine to be available by year’s end
In a wide-ranging talk with UCLA Health physicians, Wednesday, Oct. 28, United States Surgeon General Jerome Adams, MD, MPH, addressed the politicization of the pandemic and the means of containing the spread of COVID-19. He also offered hope that a vaccine for the virus will be available by year’s end.
Sociology professors publish research on vaccine refusal
Study examines “personal belief exemptions” (PBEs) to childhood vaccine requirements among certain communities in California.
Study: Turning a coronavirus protein into a nanoparticle could be key to an effective COVID-19 vaccine
One of the proteins on the virus – located on the characteristic COVID spike – has a component called the receptor-binding domain, or RBD, which is its “Achilles heel.” That is, he said, antibodies against this part of the virus have the potential to the neutralize the virus.
Key details about broadly neutralizing antibodies provide insights for universal flu vaccine
New research from an immunology team at the University of Chicago may shed light on the challenges of developing a universal flu vaccine that would provide long-lasting and broad protection against influenza viruses.
Rutgers Expert Available to Discuss Ethics of Human Challenge Trials
The first human challenge trial of a potential coronavirus vaccine — in which healthy volunteers are infected with the virus after being given different vaccines under development — is planned for January. A Rutgers expert is available to discuss the…
Building “ToxAll” — a smart, self-assembling nano-vaccine to prevent toxoplasmosis
A team of researchers at the University of Chicago have developed a self-assembling nanoparticle to create a toolbox for treating infections such as Toxoplasma gondii, a serious parasitic infection.
Serology Study Provides Critical Insight into COVID-19 Immune Response
New research in Clinical and Translational Immunology, provides a clearer picture of the protective antibodies induced by SARS-CoV-2 and their role in serious illness and what’s needed for full protection.
CARES Act funds major upgrade to Corona supercomputer for COVID-19 work
With funding from the Coronavirus Aid, Relief and Economic Security (CARES) Act, Lawrence Livermore National Laboratory, chipmaker AMD and information technology company Supermicro have upgraded the supercomputing cluster Corona, providing additional resources to scientists for COVID-19 drug discovery and vaccine research
Story Tips: Remote population counting, slowing corrosion and turning down the heat
ORNL story tips: Remote population counting, slowing corrosion and turning down the heat
Vaccine Opposition Online Uniting Around ‘Civil Liberties’ Argument
Anti-vaccination discourse on Facebook increased in volume over the last decade, coalescing around the argument that refusing to vaccinate is a civil right, according to a study published today in the American Journal of Public Health.
New Biomarkers for Glioma Treatment Response
Biomarkers using mass cytometry can assess patient response to an emerging vaccine for a specific pediatric brain tumor, according to a recent multi-center study published in the Journal of Clinical Investigation.
Science Snapshots September 2020
2D Electronics, Plant Biofactories, Transforming Waste, and Vaccine Development.
New vaccine strategy harnesses ‘foot soldier’ T-cells to provide protection against influenza
As Americans begin pulling up their sleeves for an annual flu vaccine, researchers at the University of Wisconsin–Madison have provided new insights into an alternative vaccine approach that provides broader protection against seasonal influenza.
Rutgers Expert Available to Discuss Communicating About COVID-19 Vaccine
New Brunswick, N.J. (Sept. 17, 2020) – Rutgers University–New Brunswick Professor William Hallman is available for interviews on how to communicate with the public about a potential COVID-19 vaccine. “For a COVID-19 vaccine to be embraced by the public, officials can’t…
Injectable hydrogel could someday lead to more effective vaccines
Researchers reporting in ACS Central Science developed an injectable hydrogel that allows sustained release of vaccine components, increasing the potency, quality and duration of immune responses in mice.
Professor: Information key to COVID-19 vaccine acceptance
Glen Nowak, director of the Center for Health and Risk Communication at the University of Georgia, co-authored a Perspective article addressing one of the most pressing topics facing the United States: achieving high acceptance of a vaccine for COVID-19. The…
Rutgers Bioethicist Available to Discuss Who May Get COVID-19 Vaccine First
Rutgers scholar Nir Eyal is available to discuss the ethics around who will be among the first in line to receive a COVID-19 vaccine when it’s available to the public. “Unlike other therapy treatments, vaccines help prevent the spread of…
Lack of Black and Hispanic Patients Could Jeopardize COVID-19 Vaccine
Rockville, Md. (September 3, 2020)—Only 10% of the 350,000 people who recently signed up for a coronavirus vaccine clinical trial are Black and Hispanic, according to CNN. This low number of participants is especially concerning given the disproportionately higher rates…